Activism, drug regulation, and the politics of therapeutic evaluation in the AIDS era : A case study of ddC and the 'surrogate markers' debateEPSTEIN, S.Social studies of science. 1997, Vol 27, Num 5, pp 691-726, issn 0306-3127Article

The use of Tris-Lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1DAVEY, Ross A; DAVEY, Mary W; CULLEN, Karen V et al.British journal of pharmacology. 2002, Vol 137, Num 8, pp 1280-1286, issn 0007-1188, 7 p.Article

On the HIV incubation distribution under AZT treatmentTAN, W. Y.Biometrical journal. 1995, Vol 37, Num 3, pp 319-338, issn 0323-3847Article

Traitement par la zidovudine de l'infection par le VIH : le bon usage de l'AZTREGNIER, B.La Revue du praticien (Paris). 1991, Vol 41, Num 19, pp 1801-1804, issn 0035-2640Article

Nail pigmentation changes associated with azidothymidine (zidovudine)FURTH, P. A; KAZAKIS, A. M.Annals of internal medicine. 1987, Vol 107, Num 3, issn 0003-4819, 350Article

La thérapeutique antivirale en pédiatrie = Antiviral therapy in pediatricsINGRAND, D.Annales de pédiatrie (Paris). 1987, Vol 34, Num 7, pp 572-576, issn 0066-2097Article

Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)ELWELL, L. P; FERONE, R; ZIMMERMAN, T. P et al.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 2, pp 274-280, issn 0066-4804Article

Chemotherapeutic approaches in the control of the acquired immune deficiency syndrome. IPRAKASH CHANDRA; ANGELIKA CHANDRA; ILHAN DEMIRHAN et al.AIDS - Forschung. 1987, Vol 2, Num 4, pp 196-206, issn 0179-3098Article

Passages transplacentaires de l'acyclovir et de la zidovudine : Les médicaments pendant la grossesse = Transplacental transfer of acylovir and zidovudineBERREBI, A; COHEN-KHALAS, Y.Gynécologie, revue du gynécologue. 1993, Vol 1, Num 3, pp 155-157, issn 1250-3347Article

Azidothymidine (Zidovudine) transport by the human placentaSCHENKER, S; JOHNSON, R. F; KING, T. S et al.The American journal of the medical sciences. 1990, Vol 299, Num 1, pp 16-20, issn 0002-9629Article

Strategies for experimental therapy of the retrovirus which causes AIDSBRODER, S.Annales de l'Institut Pasteur. Virologie. 1987, Vol 138, Num 1, pp 49-59, issn 0769-2617Article

Adjusting for differential rates of prophylaxis therapy for PCP in high- versus low-dose AZT treatment arms in an AIDS randomized trialROBINS, J. M; GREENLAND, S.Journal of the American Statistical Association. 1994, Vol 89, Num 427, pp 737-749, issn 0162-1459Article

Human immunodeficiency virus (HIV)-induced cell fusion: quantification and its application for the simple and rapid screening of anti-HIV substances in vitroTOCHIKURA, T. S; NAKASHIMA, H; TANABE, A et al.Virology (New York, NY). 1988, Vol 164, Num 2, pp 542-546, issn 0042-6822Article

Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutationsLENGRUBER, Renan B; DELVIKS-FRANKENBERRY, Krista A; NIKOLENKO, Galina N et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 4, pp 702-708, issn 0305-7453, 7 p.Article

Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosidesMARTIN, John C; HITCHCOCK, Michael J. M; DE CLERCQ, Erik et al.Antiviral research. 2010, Vol 85, Num 1, pp 34-38, issn 0166-3542, 5 p.Article

Effect of AZT on thymidine phosphorylation in cultured H9c2, U-937, and Raji cell linesLYNX, Matthew D; KANG, Bae-Kwang; MCKEE, Edward E et al.Biochemical pharmacology. 2008, Vol 75, Num 8, pp 1610-1615, issn 0006-2952, 6 p.Article

Synthesis and antiviral activity of new dimeric inhibitors against HIV-1DANEL, Krzysztof; LARSEN, Louise M; PEDERSEN, Erik B et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 1, pp 511-517, issn 0968-0896, 7 p.Article

L'épopée des antirétroviraux = The epic of antiretroviral therapyYENI, P.La Revue de médecine interne (Paris). 2008, Vol 29, issn 0248-8663, p. S274, SUP3Conference Paper

Medical ethics = L'éthique médicalePARKS, J. A; COX, P; JOHNSTON, J. S et al.The International journal of applied philosophy. 1999, Vol 13, Num 2, pp 165-192, issn 0739-098X, 26 p.Serial Issue

The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placentaBAWDON, R. E; SANJEEV KAUL; SOHRAB SOBHI et al.Gynecologic and obstetric investigation. 1994, Vol 38, Num 1, pp 1-4, issn 0378-7346Article

Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitroHAMMER, S. M; GILLIS, J. M.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 7, pp 1046-1050, issn 0066-4804Article

Enhancement of Zidovudine Transfer to Molt-4 Cells, a Human T-cell Model, by Dehydroepiandrosterone SulfateNISHIMURA, Tomohiro; TANAKA, Jun; TOMI, Masatoshi et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 9, pp 3959-3967, issn 0022-3549, 9 p.Article

Conjugates of betulin derivatives with AZT as potent anti-HIV agentsJUAN XIONG; KASHIWADA, Yoshiki; CHEN, Chin-Ho et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 17, pp 6451-6469, issn 0968-0896, 19 p.Article

Use of Accelerator Mass Spectrometry to Measure the Pharmacokinetics and Peripheral Blood Mononuclear Cell Concentrations of ZidovudineVUONG, Le T; RUCKLE, Jon L; BLOOD, Arlin B et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 7, pp 2833-2843, issn 0022-3549, 11 p.Article

Choix d'une combinaison fixe d'inhibiteurs nucléos(t)idiques en vue du traitement initial d'une infection à VIH : apport des données virologiques = Choice of a two nucleos(t)ide analogs fixed dose coformulation for initial antiretroviral therapy : a rational based on virological dataTAMALET, C; COLSON, P.Virologie (Montrouge). 2006, Vol 10, Num 5, pp 333-340, issn 1267-8694, 8 p.Article